
SNJ Pharma Inc. is based out of BioLabs Los Angeles, which is situated within the Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center. As the premier co-working space for life science start-ups, BioLabs Los Angeles offers a network of laboratory and office spaces nationwide. It provides state-of-the-art laboratory infrastructure, shared resources, and a collaborative community aimed at accelerating scientific discovery and innovation, particularly in addressing thrombotic disorders.

BioLabs Los Angeles has partnered with the Lundquist Institute for Biomedical Innovation, a non-profit research institute affiliated with UCLA’s David Geffen School of Medicine and Harbor-UCLA Medical Center. This collaboration features over 120 principal investigators and 400 active research projects focusing on various health issues, including thrombotic disorders. The new facility boasts 18,000 square feet of wet-lab space equipped with cutting-edge technology, including more than $1.5MM in shared molecular equipment, BSL2 cell culture rooms with incubators, and access to the Lundquist cores and vivarium facility, complete with an on-site Institutional Animal Care and Use Committee.